Cite
HARVARD Citation
Fogelman, D. et al. (n.d.). Randomized, double‐blind, phase two study of ruxolitinib plus regorafenib in patients with relapsed/refractory metastatic colorectal cancer. Cancer medicine. pp. 5382-5393. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Fogelman, D. et al. (n.d.). Randomized, double‐blind, phase two study of ruxolitinib plus regorafenib in patients with relapsed/refractory metastatic colorectal cancer. Cancer medicine. pp. 5382-5393. [Online].